Eczema cream safety during pregnancy under scrutiny in large database study

This study uses health insurance claims data to compare pregnancy outcomes in women with atopic dermatitis (eczema) who used ruxolitinib cream versus those who used a topical corticosteroid during pregnancy. Researchers will track over 5,600 women to see if there are differences in major birth defects, infant size, and pregnancy results like live births or miscarriages. The goal is to better understand the safety of ruxolitinib cream when used during pregnancy.